Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00569075 · ClinicalTrials.gov registry record

Apoptic Biomarkers of Periodontal Disease

A clinical trial, sponsored by University of Michigan.

Completed
Registry status
60
Enrollment target

NCT00569075: Completed study, sponsored by University of Michigan.

NCT00569075 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00569075 has completed, sponsored by University of Michigan.

COMPLETED
Registry status
60 participants
Enrollment target

Study Summary

The goal of this study is to facilitate early diagnosis of gum disease. Proteins associated with cell death will be isolated from gum pockets of diseased and healthy patients and evaluated.

Interventions

  • OTHER collection of gingival crevicular fluid

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2006-10
Est. Completion 2009-10
University of Michigan

1,327 total trials

What the finished NCT00569075 record still lists

NCT00569075 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which collection of gingival crevicular fluid is the first listed.

NCT00569075 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00569075 about?

NCT00569075 is a clinical study titled "Apoptic Biomarkers of Periodontal Disease". The goal of this study is to facilitate early diagnosis of gum disease. Proteins associated with cell death will be isolated from gum pockets of diseased and healthy patients and evaluated.

What is the current status of trial NCT00569075?

This trial is currently completed. The enrollment target is 60 participants. The study started on 2006-10. Estimated completion is 2009-10.

What interventions are being tested in trial NCT00569075?

The interventions under investigation include: collection of gingival crevicular fluid (OTHER).

Who is sponsoring clinical trial NCT00569075?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00569075, the US trial registry maintained by the National Library of Medicine. NCT00569075 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.